Background
Pulmonary edema is a medical emergency that threatens life, and requires urgent management and immediate hospitalization. Since there is no definite "gold standard" for diagnosing ALI/ARDS or cardiogenic pulmonary edema (CPE), there is no technique or known biomarker that can be used to distinguish between the two conditions. Combining clinical criteria with other proven diagnostic methods, such as BNP and chest ultrasonography, can increase the predicted accuracy, assist in therapy, and enhance the results.
Objective
The purpose of this study is to assess how well plasma brain natriuretic peptide (BNP) and chest ultrasonography can distinguish between cardiogenic and noncardiogenic pulmonary edema.
Patients and methods
Lung US was applied to respiratory distressed patients In Benha University Hospital Chest ICU and Emergency Department on 50 subjects through a cross-sectional prospective study. They were divided into CPE group 20 cases) and NCPE group (20 cases) as well as the control group (10 cases). Alveolar-interstitial syndrome (AIS), absence or decreased lung sliding, sparing regions, subpleural consolidation, pleural line abnormalities, and pleural effusion were among the pleuropulmonary symptoms that were targeted for detection by the LUS scan in both groups. Plasma BNP levels were assessed in all groups.
Results
Consolidation is another sonographic finding in the Non-CPE group which represents 80% of cases and is present in 5% only in the CPE group in our study. Pleural effusion is not a specific finding between the two groups but it was higher among the cardiogenic group … |
